Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07654387

Divide and Conquer With Debulking in Management of Rocky Hard Cataract

The management of nucleus may be challenging in rocky hard cataracts. Hard cataracts are difficult to fragment, and the excessive energy required to emulsify the hard nucleus can result in complications such as corneal edema, inflammation, wound burn, posterior capsular rupture, and zonular dialysis. different surgical techniques are used for the management of hard cataracts, with their advantages and limitations. Divide and conquer with debulking is a new technique for management of rocky hard cataract.

In this research we assess its safety comparing it with standard divide and conquer technique.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Cataract Mature

Age range

40 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The management of nucleus may be challenging in rocky hard cataracts. Hard cataracts are difficult to fragment, and the excessive energy required to emulsify the hard nucleus can result in complications such as corneal edema, inflammation, wound burn, posterior capsular rupture, and zonular dialysis. different surgical techniques are used for the management of hard cataracts, with their advantages and limitations. Divide and conquer with debulking is a new technique for management of rocky hard cataract.

In this research we assess its safety comparing it with standard divide and conquer technique.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adults with rocky hard cataract

Exclusion criteria

  • patients with abnormal endothelial cell count.
  • patients with glaucoma.
  • patients with retinal problems.

Treatment and study plan

cataract operation by phacoemulsification

Procedure

phacoemulsification either by standard divide and conquer or divide and conquer with debulking.

Primary outcomes

  1. endothelial cell count

    Time frame: 3 months

Study contacts

Contact information is provided by the study sponsor or research team.

Hany Mahmoud

CONTACT

[email protected]

01024368111

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jun 17, 2026
Registry last updated
Jun 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.